Odds ratio | 95 % Confidence interval | P value | ||
---|---|---|---|---|
Age, years | ||||
19–39 | Reference | |||
40–59 | 1.08 | 0.79 | 1.47 | 0.65 |
60–79 | 1.64 | 1.23 | 2.17 | 0.001 |
≥ 80 | 2.61 | 1.81 | 3.77 | <0.001 |
Sex | ||||
Male | Reference | |||
Female | 0.96 | 0.82 | 1.12 | 0.61 |
Hospital volume per year | ||||
0–9 | Reference | |||
10–19 | 0.83 | 0.68 | 1.01 | 0.07 |
≥ 20 | 0.80 | 0.63 | 1.02 | 0.07 |
Body mass index, kg/m2 | ||||
< 18.5 | 1.28 | 1.01 | 1.62 | 0.04 |
18.5–24.9 | Reference | |||
≥ 25.0 | 1.24 | 1.04 | 1.47 | 0.02 |
Etiology | ||||
Ischemic heart disease | Reference | |||
Heart failure | 0.55 | 0.46 | 0.65 | <0.001 |
Valvular disease | 0.85 | 0.66 | 1.10 | 0.22 |
Myocarditis | 0.42 | 0.31 | 0.57 | <0.001 |
Cardiomyopathy | 0.75 | 0.51 | 1.08 | 0.12 |
Takotsubo cardiomyopathy | 0.58 | 0.27 | 1.21 | 0.14 |
Infectious endocarditis | 0.69 | 0.21 | 2.28 | 0.55 |
Cardiac arrest | ||||
No | Reference | |||
Yes | 1.52 | 1.28 | 1.82 | <0.001 |
Chronic renal failure | ||||
No | Reference | |||
Yes | 0.90 | 0.69 | 1.16 | 0.40 |
Liver failure pre-ECMO | ||||
No | Reference | |||
Yes | 1.30 | 0.71 | 2.38 | 0.40 |
Central nervous system dysfunction pre-ECMO | ||||
No | Reference | |||
Yes | 0.87 | 0.45 | 1.70 | 0.68 |
Duration of intubation prior to VA-ECMO, days | ||||
0 | Reference | |||
1 | 1.03 | 0.44 | 2.39 | 0.94 |
≥ 2 | 0.47 | 0.32 | 0.70 | <0.001 |
Use of intra-aortic balloon pumping | ||||
No | Reference | |||
Yes | 0.58 | 0.49 | 0.68 | <0.001 |
Use of continuous renal replacement therapy | ||||
No | Reference | |||
Yes | 1.95 | 1.63 | 2.33 | <0.001 |